Financials
Financial year 2025
MDN Pharmaceutics from Brussel, company number BE1032175218, closed financial year 2025 with a result of € -1,127 after tax. For that financial year MDN Pharmaceutics recorded a gross margin of € -1,127 and equity of € 873. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 10, 2026.
€ 873
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1,127
Profit after tax over the fiscal year.
€ 647
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1,127.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,127
Supplier invoices still open on the last day of the fiscal year.
Ask about MDN Pharmaceutics the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to MDN Pharmaceutics?
What happened at MDN Pharmaceutics in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 1,127. filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Brussel. KBO
- Anbar Meddoun became a director. NBB
Management
Behind MDN Pharmaceutics is Anbar Meddoun.
Directors
According to the 2025 annual accounts
Anbar Meddoun
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Ieperlaan 34 box 402
1000 Brussel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 4 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Brussel
Same main activity (Detailhandel in farmaceutische producten), 57 active companies in Brussel, largest first.
VERTEX PHARMACEUTICALS (BELGIUM)
€ 88.9 million revenue · 2025
€ 2.1 million gross margin · 2025
€ 1.5 million gross margin · 2025
€ 771,406 gross margin · 2025
€ 685,436 gross margin · 2025
€ 596,330 gross margin · 2024
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- MEDDOUN Anbar(oprichter) 100%
Details
- Company number
- 1032.175.218
- VAT number
- BE 1032.175.218
- Registered office
- Ieperlaan 34 bus 402, 1000 Brussel
- Names & denominations
- MDN Pharmaceutics
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 24 December 2025
- Peppol
- Active · Active since 13 Mar 2026
- Activities · NACE
Detailhandel in farmaceutische producten
Bemiddelingsactiviteiten in verband met geneeskundige, tandheelkundige en andere diensten in verband met de menselijke gezondheid
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Bemiddelingsactiviteiten voor de gespecialiseerde detailhandel
Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen